Vascular Endothelial Growth Factor Levels in Patients Undergoing Embryo

See also
Status	Clinical Trial	Phase
Completed	`NCT02407730` - EFFects of Thrombophilia on the Outcomes of Assisted Reproduction Technologies
Not yet recruiting	`NCT06084793` - Music for Anxiety in Embryo Transfers	N/A
Active, not recruiting	`NCT03901170` - Does Letrozole Improve Pregnancy Outcome in Fresh Embryo Transfer IVF/ICSI Cycle?	Phase 4

See also

Status

Clinical Trial

Phase

Completed

NCT02407730 - EFFects of Thrombophilia on the Outcomes of Assisted Reproduction Technologies

Not yet recruiting

NCT06084793 - Music for Anxiety in Embryo Transfers

N/A

Active, not recruiting

NCT03901170 - Does Letrozole Improve Pregnancy Outcome in Fresh Embryo Transfer IVF/ICSI Cycle?

Phase 4

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT04261660
Study type	Observational
Source	Carmel Medical Center
Contact	ido Fefekorn, MD
Phone	+972-54-3537401
Email	idofe@clalit.org.il
Status	Not yet recruiting
Phase
Start date	March 1, 2020
Completion date	April 1, 2021

Vascular Endothelial Growth Factor Levels in Patients Undergoing Embryo Transfer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms